MBX, Zenas And Bicara IPOs Generate Big First Day Returns, But Will They Last?

Most New 2024 Biopharma Offerings Trade Lower Later

 
• By Mandy Jackson
  
Scrip Podcast

Have you checked out Scrip podcast?

New episodes every Thursday.

SpotifyApple PodcastsWebsite

More from Business

More from Financing